Dan Rayfield: “None of the funding will come from taxpayers, but from the money the state collects when it wins antitrust awards and…”

When you have fewer competitors in an industry, historically, that means less pressure to keep costs down.

From the beginning, this case has been about making sure that facts, not political whims, guide how the law is applied. Today’s decision protects that principle.

The lawsuit is a simple way to keep money in citizens’ pockets.

Glenmark was working with other drug companies to keep prices artificially high, and Oregon families paid for it every time they picked up a prescription. This is money out of people’s pockets for medications they needed.